Akebia Therapeutics (NASDAQ:AKBA) used its R&D Day presentation to outline a strategy centered on expanding its commercial ...

Chronic Kidney Disease (CKD) Anemia Market Overview: The global chronic kidney disease (CKD) anemia market is projected to grow at a CAGR of approximately 6% over the next five years. This growth is ...

Serum levels of B vitamins don't adequately reflect nutritional state for patients with chronic kidney disease (CKD).

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

The doctor worked at one of a chain medical center's ...

A combination of Verzenio and letrozole has shown encouraging and lasting responses in patients with advanced or recurrent ...

Chronic kidney disease affects 1 in 7 U.S. adults, underscoring the importance of early detection and management. This ...

Many cats are prone to kidney weakness or kidney insufficiency, especially as they age. Here, you'll find everything about ...

This is a developing news story. Please check back soon for updates. The FDA granted full approval to sparsentan for ...

A once-daily oral tablet, sparsentan is fully approved to reduce proteinuria in patients ages 8 and older with FSGS who do ...

France: A newly published case report in BMC Nephrology has highlighted a potential link between luspatercept therapy and a ...

Administration of aminophylline at the initiation of therapeutic hypothermia (TH) in neonates with hypoxic-ischemic encephalopathy (HIE) was associated with a greater decline in serum ...